Key clinical point: Adults with asthma–COPD overlap syndrome (ACOS) who used statins had a lower risk of anxiety and depression than nonstatin users.
Major finding: Statin users had significantly lower risks of anxiety (adjusted hazard ratio, 0.34) and depression (aHR, 0.36), compared with nonstatin users.
Study details: The data come from a retrospective cohort study of 1,252 statin users and 7,887 nonstatin users in Taiwan.
Disclosures: The study was supported by grants from a variety of organizations in Taiwan, China, and Japan. Dr. Jun-Jun Yeh and associates had no financial conflicts to disclose.
Yeh J et al. J Affect Disord. 2019 Jun 15; 253:277-84.